Insider trades
Helen Sabzevari, CEO of Precigen PGEN, has filed 1 purchase and 5 sales on the open market. Over the past 12 months that comes to a net sale of $519.9K. The latest trade was on 05/28.
Helen Sabzevari
President and CEO
- Company
- Precigen PGEN
- First filing
- 23/01/30
- Trades
- 46 trades
- Buys / sales
- 1 / 5
- 12-month net buying
- −$519.9K
- Last trade
- 05/28
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
PrecigenPGEN | Open-market sale | 05/28 | 06/01 | 119,250 sh | $4.36 | $519,930 | −3.1% |
PrecigenPGEN | Open-market sale10b5-1 plan | 23/08/25 | 23/08/25 | 76,969 sh | $1.53 | $117,762.57 | −4.7% |
PrecigenPGEN | Open-market sale10b5-1 plan | 23/08/18 | 23/08/18 | 55,855 sh | $1.66 | $92,719.3 | −3.6% |
PrecigenPGEN | Open-market sale10b5-1 plan | 23/08/11 | 23/08/11 | 41,436 sh | $1.44 | $59,667.84 | −2.9% |
PrecigenPGEN | Open-market sale10b5-1 plan | 23/08/04 | 23/08/04 | 52,870 sh | $1.10 | $58,157 | −3.9% |
PrecigenPGEN | Open-market buy | 23/01/27 | 23/01/30 | 22,857 sh | $1.75 | $39,999.75 | +2.5% |
